Opportunity Information: Apply for RFA DA 16 002
Apply for RFA DA 16 002
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Tools and Services for Designing Methodologically Rigorous Animal Studies (R41/R42)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jun 4, 2015 and posted on Jun 4, 2015.
- Applicants must submit their applications by Aug 5, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,300,000.00 to eligible and selected applicants.
- Eligible applicants include: Small businesses.
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Tools and Services for Designing Methodologically Rigorous Animal Studies (R41/R42)" (Funding Opportunity Number RFA-DA-16-002) is a National Institutes of Health (NIH) solicitation aimed specifically at small business concerns that can create practical, research-tested tools and/or services to help life science researchers design stronger in vivo animal experiments. The central focus is methodological rigor: the NIH is looking for products or service models that improve how animal studies are planned so that the resulting data are more reliable, interpretable, and reproducible. In plain terms, the opportunity is meant to support small companies that can build or validate solutions that help investigators avoid common design weaknesses in animal work, such as bias, underpowered studies, poor randomization and blinding practices, unclear outcome definitions, inconsistent protocols, and other issues that can undermine the quality of preclinical evidence.
This announcement uses the SBIR funding mechanism (R41/R42), meaning it follows the phased small business innovation structure. Phase I (R41) generally supports early-stage feasibility research and proof-of-concept development, while Phase II (R42) supports further research and development to advance the solution toward a more complete, usable, and validated offering. Within this FOA, that structure signals NIH interest not just in ideas, but in solutions that can be built, tested, refined, and positioned for real-world adoption by researchers who run animal studies. The activity category is listed under education and health, and the CFDA number 93.279 ties the opportunity to NIH's drug abuse and addiction research programs, indicating that the scientific and public health context is aligned with improving the foundations of preclinical research that may ultimately inform work relevant to substance use and addiction, even if the tools themselves could have broader utility across biomedical fields.
Only small businesses are eligible to apply. Foreign institutions are explicitly not eligible, and non-U.S. components of U.S. organizations are also not eligible; however, "foreign components" as defined in the NIH Grants Policy Statement may be allowed, which typically means certain discrete, justified elements of the work could be performed abroad if permitted under NIH policy and clearly necessary. The FOA states there is no cost sharing or matching requirement, which is important for small businesses because it means the applicant is not required to contribute non-federal funds as a condition of receiving the award.
From a funding and timing perspective, the FOA listed an estimated total funding amount of $1,300,000. The opportunity was posted and created on June 4, 2015, with an original and current closing date of August 5, 2015, and an archive date of September 5, 2015. That timeline indicates this was a targeted, time-limited solicitation rather than an always-open program announcement. Even though it is archived now, the summary still reflects the type of projects NIH was seeking under this call: SBIR-supported R and D to create tools or service offerings that measurably strengthen study design rigor in animal research.
In terms of what "tools and/or services" can mean here, the FOA is broadly phrased, which typically leaves room for a range of deliverables as long as they address the core problem of improving experimental design quality. Tools might include software applications, decision-support platforms, protocol-design systems, power and sample-size planning utilities, workflow or compliance systems that enforce good practices (like randomization, blinding, and pre-specified outcomes), or other structured resources that reduce the likelihood of bias and analytical pitfalls before experiments begin. Services could include fee-for-service or scalable support models, such as methodological consultation packages, study design review services, training platforms, or hybrid models where a software tool is paired with expert guidance. The key is that the proposed product or service should be developed through research and development, not simply offered as an existing consultancy, and it should be clearly oriented toward improving rigor in in vivo animal experiments.
Administration and support for applicants is handled through NIH. The announcement provides an additional information link to the full FOA on the NIH grants website (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-002.html). For access issues, the contact point provided is the NIH Office of Extramural Research (OER) Webmaster (FBOWebmaster@OD.NIH.GOV), including help if there are problems opening the full announcement or linking to it.
Frequently Asked Questions (FAQs)
What is the official title and funding opportunity number for this grant?
The opportunity is titled "Tools and Services for Designing Methodologically Rigorous Animal Studies (R41/R42)" and the Funding Opportunity Number is RFA-DA-16-002.
Which agency is offering this opportunity?
This is a National Institutes of Health (NIH) solicitation.
What is the main purpose of this funding opportunity?
The purpose is to support small businesses that can create practical, research-tested tools and/or services that help life science researchers design stronger in vivo animal experiments, with a central emphasis on methodological rigor so results are more reliable, interpretable, and reproducible.
What does "methodological rigor" mean in the context of this FOA?
Methodological rigor refers to improving how animal studies are planned to reduce weaknesses that can undermine preclinical evidence, such as bias, underpowered studies, poor randomization and blinding, unclear outcome definitions, inconsistent protocols, and other design issues that affect reliability and reproducibility.
What types of applicants are eligible to apply?
Only small business concerns are eligible to apply.
Are foreign institutions eligible to apply?
No. Foreign institutions are explicitly not eligible.
Are non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations are also not eligible under this opportunity.
Are "foreign components" allowed at all?
Yes, "foreign components" (as defined in the NIH Grants Policy Statement) may be allowed. This typically means discrete, justified elements of the work could be performed abroad if permitted under NIH policy and clearly necessary.
What funding mechanism does this opportunity use?
This opportunity uses the SBIR funding mechanism with the R41/R42 activity codes.
How do Phase I (R41) and Phase II (R42) differ in this solicitation?
Phase I (R41) generally supports early-stage feasibility research and proof-of-concept development. Phase II (R42) supports further research and development to advance the solution toward a more complete, usable, and validated offering.
What kind of projects is NIH looking for under this SBIR call?
NIH is looking for solutions that can be built, tested, refined, and positioned for real-world adoption by researchers who run animal studies, rather than ideas alone.
What kinds of deliverables count as "tools" under this FOA?
The FOA is broadly phrased, but examples of tools include software applications, decision-support platforms, protocol-design systems, power and sample-size planning utilities, and workflow or compliance systems that enforce good practices such as randomization, blinding, and pre-specified outcomes.
What kinds of deliverables count as "services" under this FOA?
Services may include fee-for-service or scalable support models such as methodological consultation packages, study design review services, training platforms, or hybrid models where software is paired with expert guidance, as long as the offering is developed through research and development and is oriented toward improving rigor in in vivo animal experiments.
Does NIH allow applications that are simply offering an existing consultancy?
The FOA emphasizes research and development to develop tools or service offerings, rather than simply offering an existing consultancy without an R&D development component.
What specific study design weaknesses is this opportunity trying to address?
The opportunity is meant to help investigators avoid weaknesses such as bias, underpowered studies, poor randomization and blinding practices, unclear outcome definitions, inconsistent protocols, and other issues that can undermine the quality of preclinical evidence.
What is the activity category for this opportunity?
The activity category is listed under education and health.
What is the CFDA number associated with this opportunity?
The CFDA number is 93.279.
What does the CFDA number indicate about the scientific or public health context?
CFDA 93.279 ties the opportunity to NIH's drug abuse and addiction research programs, indicating alignment with improving the foundations of preclinical research that may ultimately inform work relevant to substance use and addiction, even if the tools themselves could be useful across many biomedical fields.
Is there a cost sharing or matching requirement?
No. The FOA states there is no cost sharing or matching requirement.
How much total funding was estimated for this opportunity?
The FOA listed an estimated total funding amount of $1,300,000.
When was the opportunity posted?
The opportunity was posted and created on June 4, 2015.
What was the closing date for applications?
The original and current closing date listed was August 5, 2015.
Is this opportunity still open?
No. The opportunity is archived, with an archive date of September 5, 2015, indicating it was a targeted, time-limited solicitation rather than an always-open program announcement.
Where can applicants find the full funding opportunity announcement?
The FOA link provided is: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-002.html
Who should be contacted if there are technical issues accessing the full announcement?
For access issues (such as problems opening the full announcement or linking to it), the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: Agriculture Risk Management Education Partnerships (ARME) Competitive Grants Program
Previous opportunity: Cooperative Ecosystem Studies Unit, Piedmont South Atlantic Coast CESU
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 16 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 16 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Tools and Services for Designing Methodologically Rigorous Animal Studies (R43/R44) Apply for RFA DA 16 003 Funding Number: RFA DA 16 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Career Development Program in Emergency Care Research (K12) Apply for RFA HL 16 019 Funding Number: RFA HL 16 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Harnessing Big Data to Halt HIV (R01) Apply for PA 15 273 Funding Number: PA 15 273 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Smoking Cessation within the Context of Lung Cancer Screening (R01) Apply for RFA CA 15 011 Funding Number: RFA CA 15 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R01) Apply for PAR 15 274 Funding Number: PAR 15 274 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R21) Apply for PAR 15 275 Funding Number: PAR 15 275 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Turkey US Collaborative Program for Affordable Medical Technologies (R01) Apply for PAR 15 276 Funding Number: PAR 15 276 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R01) Apply for PAR 15 280 Funding Number: PAR 15 280 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R03) Apply for PAR 15 281 Funding Number: PAR 15 281 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21) Apply for PAR 15 282 Funding Number: PAR 15 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R21) Apply for PAR 15 284 Funding Number: PAR 15 284 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R01) Apply for PAR 15 283 Funding Number: PAR 15 283 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| The Pancreatic Cancer Detection Consortium (U01) Apply for PAR 15 289 Funding Number: PAR 15 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Apply for PAR 15 297 Funding Number: PAR 15 297 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44) Apply for RFA DA 16 005 Funding Number: RFA DA 16 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42) Apply for RFA DA 16 006 Funding Number: RFA DA 16 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Supplements to Support Evaluation of the NCI Cancer Genomics Cloud Pilots (Admin Supp) Apply for PA 15 305 Funding Number: PA 15 305 Agency: National Institutes of Health Category: Education Health Funding Amount: $40,000 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R01) Apply for PA 15 311 Funding Number: PA 15 311 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R21) Apply for PA 15 310 Funding Number: PA 15 310 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Imaging Science Track Award for Research Transition (I/START) (R03) Apply for PAR 15 326 Funding Number: PAR 15 326 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 16 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
